HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Prossimo Advisors LLC

Prossimo Advisors LLC reduced its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,582 shares of the company’s stock after selling 36 shares during the period. Prossimo Advisors LLC’s holdings in HCA Healthcare were worth $475,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. MML Investors Services LLC increased its holdings in HCA Healthcare by 31.7% during the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after purchasing an additional 4,285 shares during the period. Meritage Group LP acquired a new stake in HCA Healthcare in the third quarter valued at approximately $150,548,000. Galvin Gaustad & Stein LLC acquired a new position in HCA Healthcare during the 4th quarter worth approximately $18,044,000. Alpha DNA Investment Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter worth $869,000. Finally, NRI Wealth Management LC purchased a new position in HCA Healthcare in the fourth quarter valued at $2,896,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HCA. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. Bank of America cut their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Truist Financial cut their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Royal Bank of Canada dropped their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. Finally, Barclays dropped their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Stock Up 0.2 %

Shares of NYSE:HCA opened at $316.95 on Wednesday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The company has a market cap of $80.28 billion, a price-to-earnings ratio of 14.43, a PEG ratio of 1.11 and a beta of 1.64. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The firm’s 50-day simple moving average is $313.19 and its 200-day simple moving average is $351.50.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the company posted $5.90 earnings per share. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Insider Activity

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.